Enliven Therapeutics, Inc is a biopharmaceutical company based in Boulder, CO, dedicated to advancing medicine and restoring lives for people with cancer. Their team of seasoned drug hunters specializes in the discovery and development of small molecule kinase inhibitors, aiming to enhance efficacy, combat resistance, address brain metastases, and improve safety and patient convenience.
With a mission to help people with cancer not only live longer but live better, Enliven Therapeutics is focused on developing novel insights and precision therapeutics through their pipeline programs, including the BCR-ABL Program, HER2 Program, and additional programs. Their approach involves the development of kinase inhibitors that offer better selectivity and combinability, ultimately aiming to make a significant impact in the field of oncology.
Generated from the website